PubRank

William S Sheldrick

Author PubWeight™ 26.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties. J Med Chem 2010 1.00
2 Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type. J Med Chem 2011 0.91
3 Synthesis, structure and antimicrobial activity of manganese(II) and cobalt(II) complexes of the polyether ionophore antibiotic Sodium Monensin A. J Inorg Biochem 2007 0.88
4 A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor. J Med Chem 2009 0.87
5 Synthesis, biological activity, and structure-activity relationships for potent cytotoxic rhodium(III) polypyridyl complexes. J Med Chem 2008 0.87
6 Structure-activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS(3). J Inorg Biochem 2009 0.86
7 [N,N'-Bis(salicylidene)-1,2-phenylenediamine]metal complexes with cell death promoting properties. J Biol Inorg Chem 2009 0.85
8 Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin. Eur J Med Chem 2011 0.84
9 Dinuclear organoiridium(III) mono- and bis-intercalators with rigid bridging ligands: synthesis, cytotoxicity and DNA binding. J Inorg Biochem 2009 0.82
10 First solid state alkaline-earth complexes of monensic acid A (MonH): crystal structure of [M(Mon)2(H (2)O)2] (M = Mg, Ca), spectral properties and cytotoxicity against aerobic Gram-positive bacteria. Biometals 2009 0.82
11 Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative. Angew Chem Int Ed Engl 2009 0.81
12 Spectroscopic and structural elucidation of 4-dimethylaminopyridine and its hydrogensquarate. Spectrochim Acta A Mol Biomol Spectrosc 2008 0.81
13 On the biological properties of alkynyl phosphine gold(I) complexes. Angew Chem Int Ed Engl 2012 0.81
14 Identification of (eta6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(eta6-p-cymene)RuCl2 (DMSO)] to stress-regulated proteins and to helicases. J Biol Inorg Chem 2007 0.81
15 Crystal structure and properties of the copper(II) complex of sodium monensin A. J Inorg Biochem 2009 0.81
16 2-amino-4-nitroaniline, a known compound with unexpected properties. J Phys Chem A 2007 0.81
17 First divalent metal complexes of the polyether ionophore Monensin A: X-Ray structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their bactericidal properties. Curr Drug Discov Technol 2008 0.80
18 Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules. Dalton Trans 2012 0.80
19 Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry. J Biol Inorg Chem 2007 0.80
20 Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells. J Inorg Biochem 2011 0.79
21 The influence of methionine-containing peptides on the reaction of carboplatin with 5'-guanosine monophosphate: a comparison with cisplatin. J Inorg Biochem 2003 0.79
22 Cytotoxicity and cellular impact of dinuclear organoiridium DNA intercalators and nucleases with long rigid bridging ligands. Dalton Trans 2012 0.79
23 Cisplatin mediates selective downstream hydrolytic cleavage of Met-(Gly)(n)-His segments (n=1,2) in methionine- and histidine-containing peptides: the role of ammine loss trans to the initial Pt-S(Met) anchor in facilitating amide hydrolysis. J Inorg Biochem 2006 0.79
24 Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators. ChemMedChem 2014 0.79
25 Cell-selective, apoptosis-inducing rhodium(III) crown thiaether complexes. ChemMedChem 2010 0.78
26 Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes. Biometals 2011 0.78
27 Cellular selectivity and biological impact of cytotoxic rhodium(III) and iridium(III) complexes containing methyl-substituted phenanthroline ligands. ChemMedChem 2011 0.78
28 A simple route for renewable nano-sized arjunolic and asiatic acids and self-assembly of arjuna-bromolactone. Beilstein J Org Chem 2008 0.78
29 Synthesis and cellular impact of diene-ruthenium(II) complexes: a new class of organoruthenium anticancer agents. J Inorg Biochem 2011 0.77
30 Cytotoxic rhodium(III) and iridium(III) polypyridyl complexes: structure-activity relationships, antileukemic activity, and apoptosis induction. ChemMedChem 2009 0.77
31 Cisplatin-mediated selective hydrolytic cleavage of methionine-containing peptides with neighboring serine or histidine residues. J Inorg Biochem 2004 0.77
32 Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry. ChemMedChem 2008 0.76
33 Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts. J Biol Inorg Chem 2012 0.76
34 Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells. Bioorg Med Chem 2008 0.75
35 Atomic absorption spectrometric determination of the iridium content in tumor cells exposed to an iridium metallodrug. J Pharm Biomed Anal 2008 0.75
36 Synthesis, spectroscopic and structural elucidation of tyrosinamide hydrogensquarate monohydrate. Amino Acids 2008 0.75
37 Tyrammonium 4-nitrophthalate dihydrate: structural and spectroscopic elucidation. Amino Acids 2008 0.75
38 Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity. Eur J Med Chem 2011 0.75
39 Crystal structures and spectroscopic properties of ester amide and diamide of squaric acid with prolinamide. Spectrochim Acta A Mol Biomol Spectrosc 2008 0.75
40 Synthesis, cellular uptake and structure-activity relationships for potent cytotoxic trichloridoiridium(III) polypyridyl complexes. J Inorg Biochem 2008 0.75
41 Variable coordination mode of chloranilic acid. Synthesis, structure, and electrochemical properties of some osmium complexes. Inorg Chem 2005 0.75
42 On the origin of the color in the solid state. Crystal structure and optical and magnetic properties of 4-cyanopyridinium hydrogensquarate monohydrate. J Phys Chem A 2008 0.75
43 N,N-Diethyl-N'-[(E)-4-pyridylmethylene]benzene-1,4-diamine: a combined X-ray and density functional theory study. Acta Crystallogr C 2009 0.75
44 L-Argininamidium bis(hydrogensquarate). Acta Crystallogr C 2006 0.75
45 L-Leucinamide hydrogensquarate: spectroscopic and structural elucidation. Amino Acids 2008 0.75
46 Cell response of Escherichia coli to cisplatin-induced stress. Proteomics 2011 0.75
47 Synthesis, spectroscopic and structural elucidation of sympathomimetic amine, tyraminium dihydrogenphosphate. Amino Acids 2008 0.75
48 Crystal structure and spectroscopic elucidation of 3-phenylpyridinium hydrogensquarate. Spectrochim Acta A Mol Biomol Spectrosc 2010 0.75
49 Water-soluble phosphines. 17.(1) novel water-soluble secondary and tertiary phosphines with disulfonated 1,1'-biphenyl backbones and dibenzophosphole moieties. Inorg Chem 2002 0.75
50 The biological activity of Zeise's salt and its derivatives. Angew Chem Int Ed Engl 2015 0.75
51 Synthesis, characterization, and in vitro antiproliferative activity of [salophene]platinum(II) complexes. ChemMedChem 2014 0.75